[144] Abeona Therapeutics Inc. SEC Filing

Rhea-AI Filing Summary

Abeona Therapeutics Inc. (ABEO) filed a Form 144 indicating that insider Joseph Vazzano intends to sell up to 25,335 common shares through broker Stifel Nicolaus on or about 07 July 2025 (approximate sale date 07/09/2025). The proposed transaction carries an aggregate market value of $148,354, equal to roughly 0.05 % of the company’s 51.16 million shares outstanding, and follows a prior sale of 17,795 shares for $120,314 on 06 June 2025. The stock to be sold originates from 51,733 restricted-stock units acquired on 07 July 2025 and qualifies for resale under Rule 144.

The filing contains no operational or financial updates and merely provides advance notice of a relatively small insider sale. Given the modest size of the transaction versus Abeona’s float, the market impact is expected to be minimal, although investors may monitor cumulative insider activity for sentiment cues.

Insights

Financial Analyst

TL;DR: Minor insider sale (0.05 % of shares) via Form 144; routine liquidity after RSU vesting; neutral valuation impact.

The $148k sale represents a de-minimis portion of ABEO’s equity and is well within Rule 144 volume limits. No change to fundamentals, cash runway, or clinical timelines is implied. Insider diversification following RSU vesting is typical and does not, by itself, signal negative outlook. I view the disclosure as non-material for valuation or credit metrics.

Corporate Governance Expert

TL;DR: Form 144 flags compliant, pre-disclosed insider trade; governance risk remains low owing to small size and transparent reporting.

The filer certifies no undisclosed adverse information and uses a reputable broker, aligning with best-practice governance. While recurring insider sales can erode investor confidence if large or clustered, this isolated, minor transaction does not raise red-flags. Overall impact on governance perception is neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	25335	148354.00	51156736	07/09/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/08/2025	Restricted Stock Units	Issuer			51733	07/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph Vazzano 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	06/06/2025	17795	120314.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Abeona Therapeutics (ABEO) disclose in the latest Form 144?

An insider plans to sell 25,335 common shares worth about $148,354 on or after 07/09/2025.

How large is the planned ABEO share sale relative to shares outstanding?

The sale represents roughly 0.05 % of Abeona’s 51.16 million shares outstanding.

Who is selling the Abeona shares and through which broker?

Joseph Vazzano intends to sell through Stifel Nicolaus & Company, located in St. Louis, Missouri.

What is the source of the shares being sold under Rule 144?

The shares come from 51,733 restricted-stock units acquired on 07/08/2025.

Has the insider sold ABEO shares recently?

Yes. The same seller disposed of 17,795 shares for $120,314 on 06/06/2025.